Private Wealth Management Group’s Catalyst Pharmaceutical CPRX Stock Holding History

Private Wealth Management Group’s Portfolio CPRX Stock Details CPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.95K	Hold	62	–	–	﹤0.01%	1172
2026 Q1	$1.54K	Buy	62 +6	+11%	+$143	﹤0.01%	1158
2025 Q4	$1.31K	Sell	56 -3	-5%	-$67	﹤0.01%	1198
2025 Q3	$1.16K	Sell	59 -21	-26%	-$432	﹤0.01%	1247
2025 Q2	$1.74K	Buy	80 +31	+63%	+$732	﹤0.01%	1126
2025 Q1	$1.19K	Sell	49 -4	-8%	-$90	﹤0.01%	1214
2024 Q4	$1.11K	Buy	+53	New	+$1.14K	﹤0.01%	1270

Other funds holding CPRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Private Wealth Management Group's CPRX Position: Q2 2026 in Review

Private Wealth Management Group held its Catalyst Pharmaceutical (CPRX) position steady in Q2 2026 at 62 shares worth $1.95K. The position accounts for ﹤0.01% of the portfolio, ranked #1172.

Private Wealth Management Group first reported a position in CPRX in Q4 2024 and has held it in 7 quarters since. 396 funds tracked by Wall St. Rank hold CPRX as of Q2 2026.

Private Wealth Management Group held 62 shares of Catalyst Pharmaceutical worth $1.95K as of Q2 2026.
Private Wealth Management Group left its Catalyst Pharmaceutical share count unchanged in Q2 2026.
Catalyst Pharmaceutical made up ﹤0.01% of Private Wealth Management Group's portfolio in Q2 2026, its #1172 holding.
Private Wealth Management Group first reported a position in Catalyst Pharmaceutical in Q4 2024 and has held it in 7 quarters since.
396 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q2 2026.

Based on Private Wealth Management Group's 13F filing for Q2 2026, filed 27 Jul 2026.